Emphysema News and Research

RSS
Emphysema is a debilitating disease that afflicts more than three million Americans. The disease is caused primarily by smoking and leads to a progressive, irreversible breakdown of lung tissue. This breakdown reduces the amount of lung tissue available for gas exchange and also impairs the lung's ability to inflate and deflate normally. As the disease advances, the most damaged areas of the lung over inflate within the chest cavity, trapping air and preventing the healthier lung areas from functioning normally. Eventually breathing becomes more difficult, leaving patients constantly feeling out-of-breath.
Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

Self-management program with customized action plan results in better outcomes for COPD patients

Self-management program with customized action plan results in better outcomes for COPD patients

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

People with severe emphysema may breathe better after EBV therapy, study shows

People with severe emphysema may breathe better after EBV therapy, study shows

New Global Burden of Disease study estimates vast impact of asthma and COPD

New Global Burden of Disease study estimates vast impact of asthma and COPD

University of Birmingham secures NIHR funding to launch Global Health Research Group

University of Birmingham secures NIHR funding to launch Global Health Research Group

COPD can result in structural changes that affect the lung and microbiome

COPD can result in structural changes that affect the lung and microbiome

Cigarette smoking causes diverse harm that extends way beyond the lungs

Cigarette smoking causes diverse harm that extends way beyond the lungs

Researchers use artificial intelligence to predict patient's lifespan

Researchers use artificial intelligence to predict patient's lifespan

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

CT-measured vascular pruning linked to mortality risk in smokers without COPD

CT-measured vascular pruning linked to mortality risk in smokers without COPD

Scientists create graphene-based sensor to predict onset of asthma attacks

Scientists create graphene-based sensor to predict onset of asthma attacks

Smokers with diminished chest muscle may face greater mortality risk, research shows

Smokers with diminished chest muscle may face greater mortality risk, research shows

Clinical trial offers new hope for patients suffering from severe lung disease

Clinical trial offers new hope for patients suffering from severe lung disease

Anti-smoking drug safe for COPD patients, research suggests

Anti-smoking drug safe for COPD patients, research suggests

Clemson University researcher receives NIH grant to advance study into abdominal aortic aneurysms

Clemson University researcher receives NIH grant to advance study into abdominal aortic aneurysms

New research effort aims to better understand impact and progression of COPD

New research effort aims to better understand impact and progression of COPD

Immune cell study could signal new approach to tackling infections

Immune cell study could signal new approach to tackling infections

New study reveals potential drug to combat life-threatening effects of COPD

New study reveals potential drug to combat life-threatening effects of COPD